Feedback / Questions
Columvi (glofitamab-gxbm) - Roche
Columvi: Regulatory submissions in US/EU for r/r MCL in 2027
(Roche)
-
Oct 22, 2026 -
Q3 2026 Results
EMA filing • FDA filing
•
Hematological Malignancies • Mantle Cell Lymphoma • Oncology
https://assets.roche.com/f/176343/x/214d9ddfff/irp261022.pdf
Oct 22, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next